Table 2.
Description | Selected reviews | Relevance to sleep and plasticity |
---|---|---|
Neurodevelopmental hypothesis | ||
Disturbances during critical periods of brain development results in lesions that produce the symptoms of schizophrenia. Disturbances could result from genetic or environmental factors. | Fatemi and Folsom (2009), Rapoport et al. (2012) |
|
Dysconnection hypothesis | ||
Abnormal modulatory activity of neurotransmitters including DA, ACh, and 5-HT results in altered regulation of NMDA-receptor-mediated plasticity. The resulting abnormal functional integration between brain regions gives rise to symptoms of schizophrenia. | Stephan et al. (2009) |
|
Dopamine hypothesis | ||
Multiple environmental and genetic factors lead to increased presynaptic striatal dopaminergic function. Dysregulation of dopamine-driven circuits of stimulus salience and reward lead to the positive and negative symptoms of schizophrenia. | Howes and Kapur (2009) |
|
NMDAR hypofunction hypothesis | ||
NMDAR antagonists produce schizophrenia-like symptoms in humans and animals, leading to the hypothesis that NMDAR hypofunction is a core pathological mechanism of schizophrenia. This hypofunction impacts other neurotransmitter systems and may result from genetic and non-genetic factors early in life. | Gilmour et al. (2012), Olney et al. (1999) |
|
Genetic hypotheses | ||
A single genetic cause of schizophrenia is unlikely. Genetic hypotheses propose polygenic inheritance patterns, post-fertilization mutations due to genetic or epigenetic factors, or some combination of these. | Kim et al. (2011), Owen (2012) |
|
ACh acetylcholine; COMT SNP catechol-o-methyl transferase single nucleotide polymorphism; DISC-1 disrupted-in-schizophrenia-1; DA dopamine; 5-HT serotonin; NMDAR N-methyl-D-aspartate receptor; PFC prefrontal cortex; TRN thalamic reticular nucleus